Innate Pharma SA (Euronext: IPH, Nasdaq: IPHA) announced the completion of enrollment in the dose escalation portion of its Phase ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE